Breaking News, Financial News

Johnson & Johnson

Recalls, generics hurt revenues

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Johnson & Johnson 2Q10 2Q Revenues: $15.3 billion (+1%) 2Q Earnings: $3.4 billion (+7%) YTD Revenues: $31.0 billion (+2%) YTD Earnings: $8.0 billion (+19%) Comments: Excluding the effects of currency fluctuation, revenues were virtually flat in 2Q10. U.S. pharma revenues dropped 2% to $3.1 billion, while international pharma sales rose 5% to $2.4 billion. Consumer products dropped 14% in the quarter to $1.5 billion, a result of product recalls at McNeil Consumer Healthcare. Fo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters